DECanBio
HOME  
  PROJECT  
  PARTNERS  
PUBLICATIONS  
DISSEMINATION  
INTRANET  
CONTACT US  



DECanBIO
 

Novel MS-based strategies to Discover and Evaluate Cancer Biomarkers in urine: Application to Diagnosis of Bladder Cancer
 

 

DECanBio project is designed to implement a strategy for protein biomarker discovery and validation relying on use of « state of the art » mass spectrometry instrumentation for quantitative analysis of proteins.

Translating clinical ‘omics’-technology (genomics, proteomics, metabolomics) into innovative cancer biomarkers aiding in early diagnosis, prognosis and treatment selection of cancer patients 

DECanBio project is funding by the EUROPEAN COMMUNITY under the SEVENTH FRAMEWORK PROGRAMME HEALTH (EC contribution: 2.9 M€, duration 4 years from 2008 to 2012)

 

  LATEST NEWS AND INFORMATIONS
  •   2010 December 10th
 Final Update of the DECanBio Urinary Proteome AMT Tag database

  DECanBio Meeting Updates
  • 2012 June 25th  

Final DECanBio Meeting in Paris (France)

  • 2010 November 4th to 5th 

4th DECanBio General Meeting in Athens (Greece)

  • 2010 June 16th to 17th 

3rd DECanBio General Meeting in Luxembourg (Luxembourg)

  • 2009, October 22nd 

2nd DECanBio General Meeting in Munich (Germany)

  • •2009, March 2d to 4th 

1st DECanBio General Meeting in Lyon (France)

  • •2008, Oct 10th to 16th

 International Bladder Cancer Network in Barcelona (Spain)

  • •2008, Oct 2d, Sept 30

EUROKUP consortium meeting in Bergamo (Italy)

  • •2008, Apr 2d to 4th

Kick off meeting in Le Sappey en Chartreuse (France)  


Site Internet DECANBIO - Last update : 02/10/2012 10:58:22 - Legal Notice
© CEA 2003-2014 All Rights Reserved